Explore 3 Stock Ideas & Industry Insights Download Free Report

800-234-336
Shopping Cart 0
countryflagNZ
Login

AptarGroup Inc

Healthcare US ATR

112.55USD
0.02(0.02%)

Last update at 2026-06-04T20:00:00Z

Day Range

111.54115.75
LowHigh

52 Week Range

102.83163.04
LowHigh

Fundamentals

  • Previous Close 112.53
  • Market Cap8156.27M
  • Volume337581
  • P/E Ratio21.51
  • Dividend Yield1.40%
  • EBITDA803.58M
  • Revenue TTM3777.18M
  • Revenue Per Share TTM57.46
  • Gross Profit TTM 1404.73M
  • Diluted EPS TTM5.89

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 491.38M 469.76M 374.82M 334.70M 321.65M
Minority interest 0.29M 0.36M -0.19700M -0.26700M 0.46M
Net income 392.79M 374.54M 284.49M 239.29M 244.10M
Selling general administrative 606.50M 582.23M 555.40M 544.26M 551.24M
Selling and marketing expenses - - - - -
Gross profit 1117.37M 1355.51M 1263.40M 1163.84M 1156.68M
Reconciled depreciation 287.36M 263.78M 243.10M 233.71M 234.85M
Ebit 544.12M 513.66M 415.24M 379.27M 347.35M
Ebitda 831.48M 777.45M 663.84M 617.94M 605.32M
Depreciation and amortization 287.36M 263.78M 248.59M 238.67M 257.98M
Non operating income net other - - - - -
Operating income 510.88M 496.50M 404.02M 379.27M 347.35M
Other operating expenses 3266.31M 3086.39M 3083.43M 2936.38M 2856.63M
Interest expense 52.74M 43.90M 40.42M 40.83M 30.28M
Tax provision 98.88M 95.59M 86.56M 95.15M 78.02M
Interest income 34.15M 12.10M 2.94M 2.70M 22.60M
Net interest income -41.06100M -31.79700M -37.12200M -38.12700M -26.61600M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 98.88M 95.59M 90.65M 95.15M 78.02M
Total revenue 3777.18M 3582.89M 3487.45M 3322.25M 3227.22M
Total operating expenses 606.50M 859.01M 859.38M 777.97M 786.10M
Cost of revenue 2659.81M 2227.38M 2224.05M 2158.41M 2070.54M
Total other income expense net -19.49700M -26.73200M -29.19400M -44.56900M -25.69300M
Discontinued operations - - - - -
Net income from continuing ops 392.50M 374.18M 281.32M 239.56M 243.64M
Net income applicable to common shares 392.79M 374.54M 284.49M 239.29M 244.10M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 5252.72M 4432.28M 4451.89M 4203.46M 4141.36M
Intangible assets 255.34M 254.77M 283.21M 315.74M 362.34M
Earning assets - - - - -
Other current assets 142.35M 132.34M 116.73M 124.77M 121.73M
Total liab 2540.49M 1946.35M 2130.59M 2135.25M 2156.76M
Total stockholder equity 2668.10M 2471.89M 2306.82M 2053.93M 1969.41M
Deferred long term liab - - - - -
Other current liab 407.52M 369.60M 404.01M 393.99M 320.65M
Common stock 0.73M 0.72M 0.72M 0.71M 0.70M
Capital stock 0.73M 0.72M 0.72M 0.71M 0.70M
Retained earnings 2642.55M 2370.54M 2109.82M 1929.24M 1789.41M
Other liab - - - 122.53M 267.25M
Good will 1077.90M 936.26M 963.42M 945.63M 974.16M
Other assets 604.78M -1478.38300M - 57.14M 533.12M
Cash 402.42M 223.84M 223.64M 141.73M 122.92M
Cash and equivalents 402.42M 223.84M - 141.73M 122.92M
Total current liabilities 1166.44M 1068.28M 1251.31M 917.18M 982.49M
Current deferred revenue 74.83M 64.42M 60.51M 80.11M 86.95M
Net debt 1128.48M 852.22M 961.03M 1033.66M 1073.73M
Short term debt 343.53M 338.29M 458.22M 122.79M 289.63M
Short long term debt 343.53M 338.29M 458.22M 122.79M 285.88M
Short long term debt total 1530.90M 1076.07M 1184.67M 1175.39M 1196.65M
Other stockholder equity 211.20M 530.10M 505.02M 465.35M 495.33M
Property plant equipment 1676.48M 1511.36M - 1402.34M 1275.88M
Total current assets 1893.56M 1478.38M 1549.28M 1430.29M 1358.21M
Long term investments 131.03M 146.27M 49.20M 52.31M 59.48M
Net tangible assets - - - 792.56M 995.25M
Short term investments 7.11M 2.34M - 89.42M 0.74M
Net receivables 803.83M 658.06M 695.86M 676.99M 671.35M
Long term debt 1139.43M 688.07M 681.19M 1052.60M 907.02M
Inventory 537.85M 461.81M 513.05M 486.81M 441.46M
Accounts payable 340.56M 295.97M 328.57M 320.28M 285.26M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -186.38200M -429.47500M -308.73400M -341.36600M -316.04100M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -421.20300M
Accumulated amortization - - - - -
Non currrent assets other 152.71M 105.24M 69.64M 411.00M 533.12M
Deferred long term asset charges - - - - -
Non current assets total 3359.16M 2953.89M 2902.61M 2773.17M 2783.16M
Capital lease obligations 47.94M 49.72M 45.27M 42.95M 51.75M
Long term debt total 1139.43M 688.07M - 1052.60M 907.02M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -2.89400M -396.72100M -312.57900M -295.64200M -4.93300M
Change to liabilities - - - 55.10M 52.30M
Total cashflows from investing activities -330.63600M -396.72100M -324.46300M -295.64200M -457.23900M
Net borrowings 394.06M -97.46000M -51.55200M 4.99M 36.95M
Total cash from financing activities -78.26100M -225.34400M -171.55400M -162.09600M -81.51800M
Change to operating activities - - - -28.88500M -14.15700M
Net income 392.79M 374.18M 284.18M 239.56M 243.64M
Change in cash 178.08M 0.20M 81.41M 19.81M -182.04500M
Begin period cash flow 224.34M 224.14M 142.73M 122.92M 304.97M
End period cash flow 402.42M 224.34M 224.14M 142.73M 122.92M
Total cash from operating activities 570.00M 643.41M 575.24M 478.62M 363.44M
Issuance of capital stock - - - - -
Depreciation 287.36M 263.78M 248.59M 233.71M 234.85M
Other cashflows from investing activities 3.56M -1.23400M 4.91M 19.97M -1.18200M
Dividends paid 120.78M 114.06M 103.68M -99.46100M -98.50900M
Change to inventory -10.64600M 21.90M -10.64100M -60.35400M -79.96100M
Change to account receivables -73.88800M -18.07900M 15.43M -27.93700M -133.42000M
Sale purchase of stock -365.00500M -68.63800M -47.55200M -92.12600M -78.14800M
Other cashflows from financing activities -4.63400M 54.81M 31.23M 333.41M -1.71800M
Change to netincome - - - 50.62M 54.19M
Capital expenditures 270.42M 294.19M 318.40M 315.62M 307.94M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -125.44900M -32.26000M 5.75M -44.99700M -169.69500M
Stock based compensation 43.94M 47.65M 41.29M 40.94M 38.87M
Other non cash items 26.98M 11.47M 15.31M 21.52M 30.13M
Free cash flow 299.58M 349.22M 256.84M 163.00M 55.51M

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ATR
AptarGroup Inc		 0.02 0.02% 112.55 21.51 24.21 2.16 3.03 2.44 11.07
ISRG
Intuitive Surgical Inc		 11.53 2.83% 418.82 73.05 61.73 19.15 10.25 18.41 59.92
ESLOF
EssilorLuxottica Société anonyme		 - -% 201.48 44.84 27.62 4.07 2.49 3.71 16.04
ESLOY
Essilor International SA		 4.49 4.57% 102.66 41.68 27.25 3.94 2.45 3.71 16.04
BDX
Becton Dickinson and Company		 3.95 2.71% 149.56 25.56 12.48 2.59 1.76 2.89 12.55

Reports Covered

Stock Research & News

View All

Profile

AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty, and Closures. It provides dispensing pumps used to dispense sprays, liquids, or lotions from non-pressurized containers; fine-mist pumps for pharmaceutical and fragrance applications; and lotion pumps for viscous formulations, as well as closures, such as dispensing and non-dispensing solutions that enable product delivery without removal of the cap and used across various consumer end markets. The company also offers aerosol valves used in pressurized containers and continuous spray and metered-dose valves for pharmaceutical, personal care, and household applications; elastomeric primary packaging components; active material science solutions; and digital health solutions. The company primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

AptarGroup Inc

265 Exchange Drive, Crystal Lake, IL, United States, 60014

Key Executives

Name Title Year Born
Mr. Stephan B. Tanda Pres, CEO & Exec. Director 1965
Mr. Robert W. Kuhn Exec. VP & CFO 1962
Mr. Gael Touya Pres of Aptar Pharma 1970
Mr. Marc Prieur Pres of Aptar Beauty + Home 1966
Ms. Xiangwei Gong Pres of Aptar Asia 1970
Mr. Matthew DellaMaria Sr. VP of Investor Relations & Communications NA
Ms. Kimberly Y. Chainey Exec. VP, Chief Legal Officer & Corp. Sec. 1976
Ms. Shiela Pallerne Vinczeller Chief HR Officer 1964
Mr. Heidi Tlili Pres of Aptar Food + Beverage 1975
Mr. Stephan B. Tanda President, CEO & Executive Director 1965

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.